tiprankstipranks
Trending News
More News >
Sigyn Therapeutics (SIGY)
OTHER OTC:SIGY
US Market
Advertisement

Sigyn Therapeutics (SIGY) Income Statement

Compare
12 Followers

Sigyn Therapeutics Income Statement

Last quarter (Q2 2025), Sigyn Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Sigyn Therapeutics's net income was $-1.45M. See Sigyn Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -8.86K$ -10.45K-$ -11.30K
Operating Expenses
$ 2.52M$ 2.46M$ 2.15M$ 2.01M$ 916.43K
Depreciation and Amortization
$ 817.59K$ 8.86K$ 10.45K$ 19.15K$ 11.30K
EBITDA
$ -2.52M$ -2.45M$ -2.14M$ -2.53M$ -905.13K
Operating Income
$ -2.52M$ -2.46M$ -2.15M$ -2.01M$ -916.43K
Other Income/Expenses
$ -820.97K$ -1.69M$ -782.55K$ -996.40K$ -343.16K
Pretax Income
$ -3.34M$ -4.15M$ -2.93M$ -3.00M$ -1.26M
Net Income
$ -3.34M$ -4.15M$ -3.71M$ -3.40M$ -1.60M
Per Share Metrics
Basic EPS
$ -2.51$ -3.77$ -3.97$ -0.09$ -0.22
Diluted EPS
$ -2.51$ -3.77$ -3.97$ -0.09$ -0.22
Weighted Average Shares Outstanding
1.33M 1.10M 934.00K 36.40M 7.35M
Weighted Average Shares Outstanding (Diluted)
1.33M 1.10M 934.00K 36.40M 7.35M
Currency in USD

Sigyn Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis